GSDMD and myocardial infarction: Genetic ablation of key pyroptosis mediators confers cardioprotection: mice lacking gasdermin D (GSDMD) have significantly reduced infarct sizes, less cardiomyocyte death, and improved post-MI cardiac function compared to wild-type mice (10–12).